United States, Europe, Asia, and the Middle East comprise this installment of the AJRA, with diverse topics to interest both clinicians and scientists. Novel biomarkers for predicting polyps status, topical therapy to improve nasal continuous positive airway pressure (CPAP) compliance, and the use of gels and/or stents to improve surgical outcomes are among the many interesting articles available to the reader.
Inflammatory upper airway disorders remain among the most common chronic conditions that confront primary health care providers and otolaryngologists. Most recent estimates indicate that the overall cost of chronic rhinosinusitis (CRS) to the American population exceeds 20 billion dollars per year. 1 Although patients often look to surgery as a "cure" for their condition, most clinicians would agree that the main role of surgery is to reduce the inflammatory burden and improve the access of the sinuses to topical medications. It is not until the complex inflammatory pathways are completely discerned that a "cure" will ever be achievable. An important step forward toward this requires an understanding of the pathophysiology at an immunologic level. The relatively recent discovery of the regulatory T cells and their role in CRS was a significant breakthrough. These cells seem to play a central immunomodulatory role in inflammatory nasal disease and may hold the key to controlling the dysregulated inflammation seen in these conditions.
In this issue of the AJRA, Palmer et al., 2 provided a comprehensive review of the role of regulatory T cells in upper airways inflammation and identified current deficiencies in our understanding of their function. Defective cytotoxic T-cell function has similarly also been implicated in the dysregulated immune response seen in CRS. 3 A novel study by Smith et al., 4 also published in this issue, set out to explore the mechanism behind this. In their study of patients with CRS with and without polyps, the investigators observed a decrease in the local production of the important cytotoxic T-cell mediators, granzyme B, and perforin, despite an increase in absolute cytotoxic T-cell numbers in the tissue of patients with CRS. 4 They postulated that it is possible that this deficiency may affect antiviral immunity and predispose patients with CRS to an exaggerated inflammatory response after a viral insult. 4 Understanding the pathophysiology of CRS may also afford better diagnostic and monitoring techniques, and allow for new treatment development. Liu et al. 5 reported their findings on the possible use of exhaled nitric oxide as a noninvasive biomarker for classifying polyp status in patients with CRS. In their well-sized study, they demonstrated exhaled nitric oxide levels as a sensitive and specific way of differentiating patients with CRS based on polyp status. 5 Such a noninvasive biomarker may also prove a useful means of objectively monitoring disease progression or response to treatment.
The anti-inflammatory and antiproliferative properties of vitamin D are well established. Deficiencies in this essential nutrient have already been linked to many chronic diseases. 6 A recent systematic review by Stokes and Rimmer, 7 published in the AJRA last year, concluded that a significant relationship existed between lower vitamin D 3 levels and the polypoid phenotype of CRS. The findings by Konstantinidis et al., 8 published in this issue, added further support to this relationship. In addition, the investigators also noted, for the first time, an inverse correlation between positive microbial colonization and serum levels of vitamin D 3 . This work may have important therapeutic implications, particularly in the current era of searching for alternative, more natural-based therapies to combat persistent bacterial infection in our patients with CRS. Uma et al. 9 presented another possible novel therapeutic target in patients with nasal polyps. They demonstrated that metformin, a commonly used diabetic medication, may positively influence the aberrant tissue remodeling associated with nasal polyp formation through the activation of adenosine monophosphate-activated protein kinase. 9 For patients who require endoscopic sinus surgery (ESS), wound healing remains an important factor. Neo-osteogenesis, prolonged inflammation, and synechiae formation can all adversely impact postoperative outcomes. For this reason, there has been a recent increased interest in the development of agents that may optimize postoperative wound healing. Bioabsorbable agents are generally preferred over nonabsorbable ones because they are thought to incite less of an inflammatory reaction, can remain in situ longer, and do not need to be removed. This was shown to improve patient comfort, and it factored positively on their self-reported "surgical experience." Chitosan, a polymer isolated from crustaceans, is one such agent that has been extensively studied due to its favorable hemostatic and antiadhesive properties. In this issue, Liu et al., 10 published the results of their systematic review concerning the use of chitosan as a biologic dressing after ESS. Their meta-analysis of six randomized controlled trials, which involved 337 patients, demonstrated a significant benefit of chitosan-based dressings in post-ESS hemostasis and synechiae formation. 10 In continuing the wound healing theme, this issue also published the results of the study by Patel et al. 11 of a rabbit model that evaluated a novel bioabsorbable, fibrinogen-based implant. The results of this study are promising, with the implant shown to be biocompatible in rabbit sinuses; furthermore, implants impregnated with fluticasone showed favorable release profiles, with the steroid released locally over 6 weeks, with negligible systemic absorption. 11 Future human studies may prove this device to be useful in patients who undergo ESS for CRS.
Practical approaches to common clinical problems faced by otolaryngologists are also included in this issue of the AJRA. With the escalating global epidemic of obesity, more and more of our patients experience obstructive sleep apnea for which they require CPAP. Nasal CPAP can cause significant nasal discomfort and is a common reason for poor compliance. La Mantia and Andaloro, 12 presented the findings of their novel study that used topically administered sodium hyaluronate as a means of mitigating these adverse effects. In their cohort of 102 patients who used CPAP, they dem- Psaltis, M.B.B.S. (hons.) onstrated that sodium hyaluronate resulted in a significant improvement in patient-reported quality-of-life scores above humidification with saline solution alone. 12 Patients randomized to this treatment also showed lower levels of nasal inflammation and faster saccharine times when compared with those who used CPAP with or with saline solution. 12 Although longer follow-up studies are required, these early results are promising and may ultimately change clinical practice in our patients with obstructive sleep apnea.
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Cerebrospinal spinal fluid leaks are another problem that face otolaryngologists and may occur in even the most experienced hands. Although primary success rates of endoscopic repair have been well documented, secondary repair success rates are less well studied. Konuthula et al. 13 reported the findings of their large systematic review in the hope of identifying factors common to those in whom primary repair failed. Similar to a previously published meta-analysis (Psaltis et al. 14 ) , these investigators found the overall secondary leak rate to be low, with a failed primary repair most commonly associated with spontaneous leaks in those with multiple leak sites. 13 This underpins the importance of well-performed multilayered closures in such patients and the management of the predisposing factors, such as increased intracranial hypertension and obesity.
A second article in this issue discussed an institution's experience with the management of the less common frontal sinus CSF leak (Jahanshahi et al. 15 ). This study reported a primary success rate on the order of 95%, with the vast majority of leaks being accessible through a Draf 2a approach; only 3 of the 23 patients required more extensive dissection of the frontal recess to access the leak site. 15 Swelling after external septorhinoplasty is a clinical issue for facial plastic surgeons. Saedi et al., 16 compared the use of two different concentrations of supratip steroid injection in their randomized controlled trial published in this issue. Although it seemed that the surgeons noticed a subjective reduction in supratip edema in both triamcinolone arms compared with controls, the patients did not. 16 Furthermore, no difference in the degree of dorsal edema was observed in a blinded analysis of surgical photographs, which did suggest the use of steroid injections after rhinoplasty surgery, and it warrants further investigation before becoming a mainstay practice. 16 In the past decade, the study of medical sociology has emerged as an important field of research. Governments and health care organizations use such information to justify funding and the allocation of medical and research resources to the community. In this issue of the AJRA, three original articles examined the effect of different societal factors on disease presentation, health care utilization, and patient satisfaction after treatment. Azar et al., 17 identified gender-specific differences in patients with CRS who underwent surgery. They found that female patients tended to report a higher 22-item Sino-Nasal Outcome Test symptom burden before surgery. 17 Although the higher prevalence of primary migraine also seen in this group may explain this to a certain degree, their female cohort, interestingly, showed higher levels of serum immunoglobulin E and fungal elements in biopsy specimens. 17 This raises the possibility of gender-based endotype differences as a contributing factor to disease presentation.
In another study, Samuelson et al. 18 reviewed the relationship between social determinants of health and the utilization of tertiary rhinology care in patients with CRS who sought care at Vanderbilt University. In their study of Ͼ1300 patients, they showed that increased age, white race, higher income, and college education were all associated with higher utilization of rhinology services. 18 To the authors own acknowledgment, this does seem somewhat contradictory to previous societal data that indicate that lower socioeconomic status is associated with a higher CRS prevalence. An interesting study that assessed societal factors that contribute to surgeon-patient disagreement in satisfaction after rhinoplasty surgery was also published in this issue. In this study from South Korea, demographic, psychological, educational, and employment factors were all assessed in a cohort of 70 patients. 19 Dissatisfied patients were younger in age, with a higher level of employment and education. 19 This interesting finding does suggest that generational and educational differences exist in patient expectations after surgery, which reinforces the need for better preoperative counseling of the procedure and its limitations.
As evidenced by the diversity of the articles selected for this issue of the AJRA, there really is something for all. General otolaryngologists, academic rhinologists, facial plastic surgeons, and public health physicians will all find something appealing to their interest. The careful selection of such articles is a real commendation to the hard work of the editorial board and speaks to the ongoing success enjoyed by the AJRA as a leading rhinology reference for all physicians. 
